BABA and 241:HK Related Headlines
Go Back- Alibaba Health (241:HK) (BABA) PT Lowered to HK$6 at CLSA
- Alibaba Health (241:HK) (BABA) PT Raised to HK$4.70 at UBS
- Alibaba Health (241:HK) (BABA) PT Raised to HK$5.20 at Goldman Sachs
- Alibaba Health (241:HK) (BABA) PT Raised to HK$9 at Citi
- Alibaba Health (241:HK) (BABA) PT Raised to HK$6.50 at JPMorgan
- Macquarie Upgrades Alibaba Health (241:HK) (BABA) to Outperform
- Macquarie Reiterates Underperform Rating on Alibaba Health (241:HK) (BABA)
